You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

Article metrics

Article menu

See original article:

Download PDFPDF

Correction
Correction: Systematic preclinical evaluation of CD33-directed chimeric antigen receptor T cell immunotherapy for acute myeloid leukemia defines optimized construct design

 

Online download statistics by month:

Online download statistics by month: October 2021 to July 2022

AbstractFullPdf
Oct 2021018825
Nov 20210808
Dec 20210488
Jan 202202811
Feb 20220133
Mar 20220175
Apr 202202112
May 202203416
Jun 20220349
Jul 20220253
Total0488100